Current Topics in Medicinal Chemistry

Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]
pp. 1644-1644(1)
Author: Balasubramaniam, Ambikaipakan

Relevance of Neuropeptide Y (NPY) in Psychiatry
pp. 1645-1659(15)
Authors: Eaton, Katherine; Sallee, Floyd R.; Sah, Renu

Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy
pp. 1660-1674(15)
Authors: Meurs, Alfred; Clinckers, Ralph; Ebinger, Guy; Michotte, Yvette; Smolders, Ilse

Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy
pp. 1675-1681(7)
Author: Kalra, Satya P.

Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
pp. 1682-1691(10)
Authors: Ruscica, M.; Dozio, E.; Motta, M.; Magni, P.

NPY and Cardiac Diseases
pp. 1692-1703(12)
Authors: McDermott, B. J.; Bell, D.

NPY and NPY Receptors in Vascular Remodeling
pp. 1704-1709(6)
Authors: Abe, Ken; Tilan, Jason U.; Zukowska, Zofia

NPY Family of Hormones: Clinical Relevance and Potential Use in Gastrointestinal Disease
pp. 1710-1720(11)
Authors: Vona-Davis, L. C.; McFadden, D. W.

NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs
pp. 1721-1733(13)
Author: MacNeil, Douglas J.

NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?
pp. 1734-1742(9)
Authors: Kamiji, M. M.; Inui, A.

NPY and Receptors in Immune and Inflammatory Diseases
pp. 1743-1752(10)
Authors: Wheway, Julie; Herzog, Herbert; Mackay, Fabienne

Molecule of the Month
pp. 1753-1753(1)
Author: Stevens, Kirk L.